AP |
Acute pancreatitis |
AIP |
Autoimmune pancreatitis |
CA19-9 |
Serum carbohydrate antigen 19-9 |
CEA |
Carcinoembryonic antigen |
CEH-EUS |
Contrast-enhanced harmonic endoscopic ultrasound |
CP |
Chronic pancreatitis |
CT |
Computed tomography |
DM |
Diabetes mellitus |
DNA |
Deoxyribonucleic acid |
DPPHR |
Duodenal-preserving pancreatic head resection |
DWI-MRI |
Diffusion-Weighted Imaging–Magnetic Resonance Imaging |
ERCP |
Endoscopic retrograde cholangiopancreatography |
EUS |
Endoscopic ultrasound |
FAP |
Familial adenomatous polyps |
18F-FDG |
2-deoxy-2-[fluorine-18]fluoro-D-glucose |
FNA |
Fine-needle aspiration |
FNB |
Fine-needle biopsy |
HBROCS |
Hereditary breast and ovarian cancer syndrome |
HoP Head of pancreas |
|
HP |
Hereditary pancreatitis |
HSP |
Heat shock protein 70 |
IgG4 |
Immunoglobulin G4 |
MDCT |
Multi-detector computed tomography |
MIC-1 |
Macrophage inhibitor cytokine |
MMP-9 |
Matrix metalloproteinase 9 |
MRCP |
Magnetic Resonance Cholangiopancreatography |
MRI |
Magnetic resonance imaging |
PAP |
Progressive acute pancreatitis |
PC |
Pancreatic cancer |
PD |
Pancreatico-duodenectomy |
PDAC |
Pancreatic ductal adenocarcinoma |
PET |
Positron emission tomography |
PHM |
Peripancreatic hypoechoic margins |
PRISMA-ScR |
Preferred Reporting Items for Systematic Reviews and Meta-analyses extension for scoping review |
RAP |
Recurrent acute pancreatitis |
αSMA |
α-smooth muscle actin |
SUVmax |
Maximum standardised uptake value |
TAUS |
Transabdominal ultrasound |
TGF-1 |
Transforming growth factor-Beta 1 |
TIC |
Time–intensity curves |
TIMP 1 |
Tissue inhibitor of metalloproteinase 1 |
uPAR |
Urokinase-type plasminogen activator receptor |